Inventor
Jerry Shay
Inventor
Dallas, TX, US
Overview
Patents· 28 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes17%
C12NMicroorganisms or enzymes17%
C12YEnzymes15%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms13%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations10%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
Y10TTechnical subjects covered by former us classification6%
Y02ATechnologies for adaptation to climate change5%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
C07DHeterocyclic compounds2%
PatentTitleYear
10,604,794Method to measure the shortest telomeres202010,577,344Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins202010,463,685Telomerase mediated telomere altering compounds201910,082,496Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis20189,856,233'Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins'20189,732,114'Compounds having anti-adhesive effects on cancer cells'20178,785,409'Compounds having anti-adhesive effects on cancer cells'20146,551,774'Diagnostic methods for conditions associated with elevated cellular levels of telomerase activity'20036,391,554'Detecting cancerous conditions by assaying for telomerase activity'20026,368,789'Screening methods to identify inhibitors of telomerase activity'20026,294,650'Inhibition of mammalian telomerase by peptide nucleic acids'20016,210,915'Telomerase extraction method'20016,194,206'Use of oligonucleotide telomerase inhibitors to reduce telomere length'20016,046,307'Modulation of mammalian telomerase by peptide nucleic acids'20006,015,710'Modulation of mammalian telomerase by peptide nucleic acids'20006,007,989'Methods of screening for compounds that derepress or increase telomerase activity'19995,989,807'Detecting cancerous conditions by assaying for telomerase activity'19995,840,495'Methods for diagnosis of conditions associated with elevated levels of telomerase activity'19985,830,644'Method for screening for agents which increase telomerase activity in a cell'19985,707,795'Therapy and diagnosis of conditions related to telomere length and/or telomerase activity'19985,695,932'Telomerase activity assays for diagnosing pathogenic infections'19975,693,474'Methods for cancer diagnosis and prognosis'19975,686,306'Methods and reagents for lengthening telomeres'19975,686,245'Methods for screening for agents which modulate telomere length'19975,648,215'Telomerase diagnostic methods'19975,645,986'Therapy and diagnosis of conditions related to telomere length and/or telomerase activity'19975,639,613'Methods for cancer diagnosis and prognosis'19975,489,508'Therapy and diagnosis of conditions related to telomere length and/or telomerase activity'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2020Patents assigned to UNIV TEXAS (25)· patent assignee history
1996–2020Based in Dallas, TX, US· patent location history
1997–2017Patents assigned to GERON CORP (6)· patent assignee history
1997–2003Patents assigned to UNIV CALIFORNIA (4)· patent assignee history
2014–2018Patents assigned to SHAY JERRY W (3)· patent assignee history
2014–2017Patents assigned to GRYAZNOV SERGEI M (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV TEXAS | 25 | 1996–2020 |
| GERON CORP | 6 | 1997–2017 |
| UNIV CALIFORNIA | 4 | 1997–2003 |
| SHAY JERRY Wself | 3 | 2014–2018 |
| GRYAZNOV SERGEI M | 2 | 2014–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Dallas, Texas, US | 28 | 1996–2020 |